| Titolo |
Pubblicato in |
Anno |
| Patisiran in ATTRv amyloidosis with polyneuropathy: "PatisiranItaly" multicenter observational study |
JOURNAL OF NEUROLOGY |
2025 |
| Safety and efficacy of chronic weekly rozanolixizumab in generalized myasthenia gravis: the randomized open-label extension MG0004 study |
JOURNAL OF NEUROLOGY |
2025 |
| Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants |
EUROPEAN JOURNAL OF NEUROLOGY |
2024 |
| Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database |
EUROPEAN JOURNAL OF NEUROLOGY |
2024 |
| Comprehensive Cardiovascular Management of Myotonic Dystrophy Type 1 Patients: A Report from the Italian Neuro-Cardiology Network |
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE |
2024 |
| Chronic inflammatory demyelinating polyneuropathy and HEV antibody
status: A case-control study from Lazio, Italy |
JOURNAL OF THE NEUROLOGICAL SCIENCES |
2024 |
| Serum neurofilament light chain levels correlate with small fiber related parameters in patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) |
NEUROLOGICAL SCIENCES |
2024 |
| Muscle MRI as a biomarker of disease activity and progression in myotonic dystrophy type 1: a longitudinal study |
JOURNAL OF NEUROLOGY |
2024 |
| Clinical, histopathologic, and genetic features of patients with myofibrillary and distal myopathies |
NEUROLOGY |
2024 |
| Neuropathic pain experience in symptomatic and presymptomatic subjects carrying a transthyretin gene mutation |
FRONTIERS IN NEUROLOGY |
2023 |
| Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy |
JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY |
2023 |
| Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies |
EUROPEAN JOURNAL OF NEUROLOGY |
2023 |
| Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study |
LANCET NEUROLOGY |
2023 |
| Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients |
NEUROLOGICAL SCIENCES |
2023 |
| Quantitative sensory testing and skin biopsy findings in late‐onset ATTRv pre‐symptomatic carriers: relationships with predicted time of disease onset (PADO) |
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM |
2023 |
| Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis? |
EUROPEAN JOURNAL OF NEUROLOGY |
2023 |
| Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors |
NEUROLOGICAL SCIENCES |
2023 |
| Real-life experience with inotersen in hereditary transthyretin amyloidosis with late-onset phenotype: Data from an early- access program in Italy |
EUROPEAN JOURNAL OF NEUROLOGY |
2022 |
| Functional and morphometric assessment of small-fibre damage in late-onset hereditary transthyretin amyloidosis with polyneuropathy: the controversial relation between small-fibre-related symptoms and diagnostic test findings |
AMYLOID |
2022 |
| Muscle MRI in immune-mediated necrotizing myopathy (IMNM). implications for clinical management and treatment strategies |
JOURNAL OF NEUROLOGY |
2022 |
